Do You Lose More Weight on a Higher Dose of Mounjaro? (October 2026)

01 · The core answer

Do higher doses of Mounjaro make you lose more weight?

On average, yes. The clearest evidence is SURMOUNT-1, which measured weight loss at three maintenance doses over 72 weeks. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² So the trend runs upward with dose.

That is an average across thousands of bodies, though. These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² A trial average describes the group, not you. Some people respond strongly at a modest dose. Others need to climb the ladder before appetite changes much.

The licence itself is careful about this. Many people settle at a maintenance dose of 5mg, 10mg or 15mg — higher is not automatically better, and your prescriber will guide the right pace.¹ The aim is the lowest dose that gives you steady progress you can tolerate, not the highest dose you can reach.

02 · Your decision

Is a higher dose right for you?

The question you are really facing is whether to stay where you are or ask for a step up. Three things help you decide. First, how long you have been on your current dose: the first weeks on 2.5mg are an adjustment phase and losses are usually modest, so a slow start says little about your eventual response.¹ Second, your trend over weeks rather than a single weigh-in. Third, how well you are tolerating the medicine.

The usual situations and the sensible next move are set out here. It is a guide for conversation with your prescriber, not a rule.

If you want to understand the process for stepping up, read how to get a higher dose of Mounjaro. Always raise the question with your prescriber rather than changing anything yourself.

03 · Next step

What to do next

If you are already on treatment, note your trend over several weeks and bring it to your next review. If you are still deciding whether to start, the Mounjaro pen is supplied after a free online consultation reviewed by a GPhC-registered prescriber, and every order starts at the licensed starting dose. For wider support, see our weight loss clinic. Mounjaro (tirzepatide) is a prescription-only medicine, used alongside a reduced-calorie diet and increased physical activity. Individual results vary.

04 · SURMOUNT-1 dose by dose

What SURMOUNT-1 shows at each dose

SURMOUNT-1 is the main trial used to answer this question. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² Every dose beat lifestyle changes alone by a wide margin, and the averages rose with each step up.

The trial also reported how many people reached particular thresholds. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.² Notice how close those three figures sit. Most people on every maintenance dose reached a meaningful loss. The higher doses added a few more people to that group, but the lower dose already worked for the large majority.

The deeper thresholds tell a different story. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² Here the higher dose does more to push people into the very large loss category.

What does this mean in plain terms? Dose matters, and it matters most for people aiming at the largest reductions. But the lower strengths are not weak. They produced substantial average losses in the same trial, which is why many people never need to go to the top of the ladder.

Why trial averages are not forecasts

These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² An average hides a wide spread. Some participants lost far more than the figure for their dose and some lost much less. Trial participants also had regular support, and the study measured results over a long period. Judge your own progress by trend over months, not by whether you match a headline number.

You should also avoid setting one trial's figures against another trial's as though they were a head-to-head contest. Different studies recruit different people and measure different things.

For a related angle, our page on whether a higher dose of Mounjaro works better looks at what "better" can mean beyond the scales.

05 · Diminishing returns explained

Why extra dose adds less each time

The gains from each step up get smaller as the dose climbs. Looking at the SURMOUNT-1 averages, the step from 10mg to 15mg adds less on average than the step from 5mg to 10mg.²

This has a practical consequence. If you are already losing steadily on a mid-range dose, moving to the top of the ladder may add only a modest extra amount on average, while still carrying the same need for tolerability. A bigger dose is a bigger exposure to the medicine, and not everyone wants or needs that.

What the licence says about stepping up

The licensed ladder is built around response and tolerance, not around a target dose. After at least 4 weeks the dose increases to 5mg, and can then step up by 2.5mg at a minimum of 4-week intervals (7.5mg, 10mg, 12.5mg) up to a maximum of 15mg weekly, depending on how you respond and tolerate it.¹ The words "depending on how you respond and tolerate it" carry real weight. A step up is a decision, not an automatic schedule.

The same label also tells us that many people settle at a maintenance dose of 5mg, 10mg or 15mg — higher is not automatically better, and your prescriber will guide the right pace.¹ Notice that the three common maintenance doses match the three doses studied in SURMOUNT-1. The 7.5mg and 12.5mg strengths are intermediate stops that let your prescriber fine-tune the pace.

How to think about the trade-off

Imagine two people. One loses steadily at a mid dose and feels well. The other has stalled and tolerates the medicine easily. The first has little reason to climb. The second may reasonably discuss a step up. The trial average is the same for both, but their situations differ, and that is why a prescriber reviews you as an individual.

Consider also what you are optimising. Some people want the greatest possible reduction. Others want a healthier weight with the fewest side effects and the least medicine. Both are legitimate goals, and the right dose depends on which is yours. Where the average gain from the next step is small, many people reasonably decide the extra exposure is not worth it.

Remember too that weight is only one outcome. Treatment is part of weight management as health management, and a dose that gives you steady progress with good tolerability is doing its job even if it is not the top of the ladder. If you want a deeper look at the highest strength, our page on higher dose tirzepatide covers it.

06 · The dose ladder

How the Mounjaro dose ladder works

Everyone starts Mounjaro on 2.5mg once a week. This starting dose is about letting your body adjust, not about weight loss itself.¹ That detail answers a question many people have: you cannot begin on a high dose to get faster results. Our page on whether you can start on a higher dose of Mounjaro explains the reasoning in more depth.

After at least 4 weeks the dose increases to 5mg, and can then step up by 2.5mg at a minimum of 4-week intervals (7.5mg, 10mg, 12.5mg) up to a maximum of 15mg weekly, depending on how you respond and tolerate it.¹

The six strengths

Mounjaro is supplied as a pre-filled multi-dose pen (KwikPen) in 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ Each KwikPen contains four weekly doses.¹³ A pen is therefore roughly a month of treatment at one strength, and moving up a strength means starting a new pen.

Doses are not interchangeable, so never try to combine or split pens yourself.

What happens at each stage

The early weeks are gentle. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.¹ If you are wondering why the scales have barely moved at the start, this is the explanation. It is normal, and it does not mean the medicine is failing you.

Experiences differ widely. Some people notice appetite change and early loss in week one, others feel little until a higher dose — both are normal.¹ Early loss includes water weight, so the trend over weeks matters more than any single weigh-in. This variation is one reason a lower dose can sometimes outperform expectations in one person while another needs more.

Injection basics at any dose

Mounjaro is injected under the skin once a week, on the same day each week, at any time of day, with or without food.¹³ There is no best time of day: what matters is consistency.

Rotate the injection site with each dose, and follow the pen's instructions. If you want more help with the practical side, your pharmacy and prescribing team can walk you through it, and needles, a sharps bin and injection guidance are included with every order.

07 · Lower dose, strong result

Why some people lose well on a lower dose

Plenty of people lose a meaningful amount on a lower maintenance dose, and the evidence supports that. In SURMOUNT-1, the average on the lowest maintenance dose studied was substantial, and the large majority of participants on it lost at least 5% of their body weight.² A lower dose is not a consolation prize.

The label reflects this. Many people settle at a maintenance dose of 5mg, 10mg or 15mg — higher is not automatically better, and your prescriber will guide the right pace.¹ If you lost more on a lower dose than on a higher one, you are not an anomaly. Individual response varies, and the average line on a graph hides a great deal of personal difference.

Things that shape your response

Dose is only one input. Your starting weight, your eating pattern, your activity, your sleep, your alcohol intake and your own biology all influence what the scales do.

Appetite is the lever the medicine pulls. Tirzepatide activates two natural gut-hormone receptors at once, GIP and GLP-1, which help regulate appetite, slow how quickly the stomach empties and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet. If a lower dose already gives you that effect, a higher dose may add little you can feel.

Why the same dose feels different

Two people on the same strength can have different experiences because their bodies respond differently and their starting points differ. Early loss also includes water weight, so quick early numbers can mislead in either direction. Judge by the trend over weeks.

The pace is deliberately gradual. Weight loss on Mounjaro is gradual by design, and trials measured results at 72 weeks — think in months, not days, and judge progress by trend, not individual weigh-ins.¹ Comparing your week-by-week progress with someone else's, or with a forum post, is rarely helpful.

Should you ask to step up anyway?

Not necessarily. If you are losing steadily, feeling well and heading towards your goal, there is usually no reason to climb. If you have stalled and tolerate treatment easily, raise it with your prescriber. For practical ideas that do not depend on dose, see how to lose more weight on Mounjaro.

08 · Pace and expectations

How quickly should results appear?

Results build slowly, and faster is not the goal. Three months in, most people are still on the lower rungs of the dose ladder, so trial-average losses at this stage are modest compared with the headline figures.¹ In SURMOUNT-1, average weight loss built month by month, and the full averages were measured at 72 weeks, not at three months.² A sensible expectation at this stage on a standard titration is mid single digits as a percentage of body weight, with wide individual variation.¹

Slower early progress does not predict failure. The dose you respond to may still be ahead of you.¹ That sentence is worth remembering if you feel behind. The ladder is designed so that the larger changes tend to arrive as the dose rises, month by month.

Why speed is the wrong question

Think in months, not days.

Rushing the ladder is not an option in any case. The licence sets a minimum interval between steps, and the starting dose is about letting your body adjust. Skipping ahead is not supported.

The formal review point

Your prescriber reviews how treatment is going. Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ Note the wording: the highest tolerated dose, not the highest licensed dose. Tolerability is part of the definition.

This is also where NICE guidance sits in the background. NICE recommends tirzepatide for adults with a BMI of at least 35 plus at least one weight-related condition, as part of a defined care pathway.⁴ Whether you are treated on the NHS or privately, the principle of a structured review is the same.

Beyond the scales

Weight is not the only thing that changes. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial-average secondary outcomes, not forecasts for you, but they explain why prescribers talk about weight management as health management rather than appearance. A dose that improves your health measures steadily may be right even if the scale moves slowly.

09 · Plateaus and stalls

What to do when weight loss stalls

A stall is not proof that you need a higher dose. Weight loss on Mounjaro is not linear — plateaus of a few weeks are normal and expected as the body adapts to a lower weight.¹ Most people who feel stuck have hit a normal pause, not a ceiling in the medicine.

Within the licence, there is a sensible order of response. First, review your food intake honestly, because portions drift back up over time. Second, protect protein and activity. Third, check the basics: sleep and alcohol. Only then discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.¹

What not to do

A plateau is not a reason to double doses or add unlicensed products.¹ Taking extra injections, bringing doses closer together or combining products you have read about online carries unknown risk and no safety data.

Missed doses and changing your day

Plateaus are sometimes blamed on irregular dosing, so keep the routine tidy. If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day. If more than 4 days have passed, skip the missed dose entirely and take the next one on your normal day — never take two doses within 3 days of each other.¹³

You can change your weekly injection day if needed, as long as at least 3 days (72 hours) have passed since your last dose.¹³ Consistency matters more than the particular day you choose.

Using the trial as perspective

Remember that the trial results come from sustained treatment alongside diet and exercise. Averages were measured at 72 weeks, and the pattern of loss built month by month rather than in a straight line.² Short pauses sit comfortably inside that pattern. Record your trend, keep your habits steady and bring the data to your monthly review.

If you want a longer checklist of habits that support treatment, our page on losing more weight on Mounjaro goes through them.

10 · Tolerability at higher doses

Dose, side effects and tolerability

Dose and tolerability are linked, which is why the ladder is gradual. The licence says the dose can step up depending on how you respond and tolerate it.¹ So tolerability is not an afterthought; it is one of the two things that decide your dose.

The commonest early effects are mild. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹ Many people choose a weekend morning to inject so early side effects fall on days off. Our detailed guide to higher dose Mounjaro side effects goes into the full picture, and you should read the patient information leaflet that comes with your pen.

If side effects are troublesome

Do not simply push on to a higher dose to see if things improve. Tell your prescriber. Staying on a dose you tolerate well can be the better choice than climbing to one you do not.

For symptoms that are new or worry you, speak to your prescriber, and you can report suspected side effects through the MHRA Yellow Card scheme.¹⁹ Reporting helps regulators monitor medicines.

Medicines that interact

Because tirzepatide slows how quickly the stomach empties, it can reduce absorption of oral contraceptives.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ If you take insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar, so tell your prescriber about everything you take.¹ These considerations apply at every dose, and a step up is a natural moment to review them with your prescriber.

Stopping and clearance

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹ This is why changes to your plan are made calmly with your prescriber rather than abruptly.

Storage across doses

Keep Mounjaro pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge not above 30°C for up to 30 days, after which it should be discarded.¹³ Keep the cap on to protect the pen from light. Higher-strength pens are stored exactly like lower ones.

Tolerability is personal, and it often improves with time on a dose. That is a good reason to give each step a fair period before deciding whether to move on.

11 · NHS, private and cost

Getting a higher dose: NHS, private and cost

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

On the NHS, the NHS prescription charge in England is £9.90 per item where it applies, and your clinician decides your dose within the same licensed ladder.

What the private route looks like

With EverydayMeds, the journey starts with a free online consultation, a short health questionnaire with no charge and no obligation. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Dispensing is by our registered pharmacy (GPhC 9012878), with same-day dispatch when ordered by 3pm and free next-day tracked delivery in temperature-controlled packaging. Saturday delivery is £14.99.

Aftercare includes ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, plus side-effect support. Repeat orders re-check suitability, and there is no auto-shipping, so you stay in control of when to step up. Supply is official LillyDirect supply, with genuine KwikPens and all strengths in stock.

Does a higher dose cost more?

Yes, strengths are priced differently. The standard price of one pen (four weeks) is £169.99 at 2.5mg, £218.99 at 5mg, £279.99 at 7.5mg, £290.99 at 10mg, £319.99 at 12.5mg and £329.99 at 15mg. Prices were checked 10 October 2026. New customers save £40 on their first order at any dose with code FIRST40, and an automatic £25 reorder discount applies to every future order (code DOSE25). Our page on whether higher doses of Mounjaro cost more explains the pricing, and the Mounjaro 10mg price page covers that popular maintenance strength.

If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices, before discounts. A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg, again before discounts.

Payment and support

You can pay by Visa or Mastercard, with Klarna and pay-monthly options available and no subscription lock-in. Our team is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat or by phone on 0333 207 0413. The free GLPTrackr app lets you record your progress so your trend is clear at review time.

12 · Using this evidence well

Putting the evidence to use

The evidence supports a clear, modest message: on average, higher doses are linked to greater weight loss, with diminishing gains at the top of the ladder, and individual response varies widely.

A practical approach

Start where everyone starts, on 2.5mg, because the starting dose is about letting your body adjust.¹ Move up at the pace your prescriber recommends. Track your trend over weeks, not days. Keep eating and activity habits steady, because treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

When you reach a dose that gives steady progress and fits your life, there is no obligation to climb further. If progress stalls and you tolerate treatment well, ask whether a step up is appropriate. If side effects trouble you, ask about holding or stepping down within the licence.

Reading other people's stories

Online threads and reviews are full of individual stories: someone who lost rapidly on a low dose, someone who needed the top dose, someone who stalled. They are interesting, but they are not evidence. A single person's story cannot tell you what your dose should be.

Mounjaro (tirzepatide) is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.

Questions to take to your review

Before a review, it helps to write down your answers to a few simple questions. How has your appetite changed on your current dose? Are the early effects after each injection settling? Has your trend over recent weeks been downward, flat or up? Are portions, protein, activity, sleep and alcohol where you want them? Do you feel you tolerate this dose comfortably? With those answers, your prescriber can judge whether to hold, step up or step down, and you will both be working from the same information.

Finally, remember that this is a long course measured in months. The trials measured results at 72 weeks. Patience, consistency and honest review do more for most people than the headline strength on the pen.

13 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹